1.00
+0.0576(+6.11%)
Currency In USD
| Previous Close | 0.94 |
| Open | 0.95 |
| Day High | 1.03 |
| Day Low | 0.95 |
| 52-Week High | 2.2 |
| 52-Week Low | 0.71 |
| Volume | 243,949 |
| Average Volume | 246,187 |
| Market Cap | 36.16M |
| PE | -4.54 |
| EPS | -0.22 |
| Moving Average 50 Days | 1.05 |
| Moving Average 200 Days | 1.09 |
| Change | 0.06 |
If you invested $1000 in Dyadic International, Inc. (DYAI) 10 years ago, it would be worth $609.7 as of December 05, 2025 at a share price of $1. Whereas If you bought $1000 worth of Dyadic International, Inc. (DYAI) shares 5 years ago, it would be worth $162.06 as of December 05, 2025 at a share price of $1.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Dyadic and BRIG BIO Sign Development & Commercialization Agreement to Bring Animal-Free Bovine Alpha-Lactalbumin to Global Nutrition Markets
GlobeNewswire Inc.
Dec 01, 2025 12:25 PM GMT
JUPITER, Fla. and WAGENINGEN, Netherlands, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Dyadic Applied BioSolutions (“Dyadic”), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes across life science, food & nutriti
Dyadic Applied BioSolutions Expands Genetic Engineering Capabilities Through CRISPR/Cas9 Commercial License with ERS Genomics
GlobeNewswire Inc.
Nov 10, 2025 12:25 PM GMT
JUPITER, Fla. and DUBLIN, Nov. 10, 2025 (GLOBE NEWSWIRE) -- ERS Genomics Limited (‘ERS’), the CRISPR licensing company, and Dyadic Applied BioSolutions, a global biotechnology company producing precision-engineered, animal-free proteins and enzymes
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025
GlobeNewswire Inc.
Oct 29, 2025 11:25 AM GMT
JUPITER, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Dyadic International, Inc. d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-